Researchers in a groundbreaking neuroimaging study have discovered that individuals with depression exhibit significantly higher levels of blood flow in various brain regions. Key findings from the study indicate that…
The Coast Guard Foundation, a non-profit organization committed to strengthening the Coast Guard community and service by supporting members and families, announced that Robert Luna, a retired Coast Guard veteran and…
Manasthali, a renowned mental health organization dedicated to offering innovative and compassionate treatment, has revitalised the life of a 28-year-old schizophrenia patient by providing him with the right support and…
Acharya Prashant, founder of PrashantAdvait Foundation and former civil service officer, interacted with IIT students on mental health. More than 1000 people from across the country participated in the session.…
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the first patient has been randomized for its Phase 2 clinical study to evaluate the efficacy, safety, and tolerability of investigational compound NBI-1070770…
Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced clearance…
Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that it has commenced sales of its second generation (Gen-2), 15 milliamp (mA) neurostimulation device into a new…
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced that its Asia Pacific strategic partner Lotus Pharmaceutical Co. Ltd (1975.TW) identified enrollment completion of the NRx clinical…
Family Care Center, one of the nation’s premier mental health providers, is celebrating the opening of its newest clinic in Nashville’s West End neighborhood. This marks the company’s fourth outpatient mental health…
Today, Nature Medicine published the results of a clinical trial, in which 30 former Navy SEALs were administered ibogaine at Ambio Life Sciences in Mexico to treat traumatic brain injuries, which they developed during their military…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
